SERUM LEVEL OF HALOPERIDOL AND ITS CLINICAL-SIGNIFICANCE

被引：32

作者：

ITOH, H ^{[1
]}

YAGI, G ^{[1
]}

OHTSUKA, N ^{[1
]}

IWAMURA, K ^{[1
]}

ICHIKAWA, K ^{[1
]}

机构：

[1] TOKAI UNIV,SCH MED,DEPT INTERNAL MED,TOKYO,JAPAN

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY | 1980年 / 4卷 / 02期

关键词：

D O I：

10.1016/0364-7722(80)90034-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：171 / 183

页数：13

共 12 条

[1] BURROWS G, 1971, CLIN PHARM THERAP, V16, P639
[2] PLASMA-LEVEL PROFILE OF HALOPERIDOL IN MAN FOLLOWING INTRAMUSCULAR ADMINISTRATION
CRESSMAN, WA
BIANCHINE, JR
SLOTNICK, VB
JOHNSON, PC
PLOSTNIEKS, J
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) : 99 - 103
[3] ERICKSEN S E, 1978, Psychopharmacology Bulletin, V14, P15
[4] FORSMAN A, 1977, CURR THER RES CLIN E, V21, P396
[5] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS
FORSMAN, A
MARTENSSON, E
NYBERG, G
OHMAN, R
[J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) : 113 - 124
[6] FORSMAN A, 1977, CURR THER RES CLIN E, V21, P606
[7] FORSMAN A, 1974, ANTIPSYCHOTIC DRUGS, P359
[8] JOHNSON PC, 1967, INT J NEUROPSYCHI S1, V3, P24
[9] MONITORING PLASMA CONCENTRATIONS OF NEUROLEPTICS
LADER, M
[J]. PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1976, 9 (04): : 170 - 177
[10] OHTSUKA N, 1978, J KEIO MED SOC, V55, P277